BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22852281)

  • 61. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension.
    Singh TP; Rohit M; Grover A; Malhotra S; Vijayvergiya R
    Am Heart J; 2006 Apr; 151(4):851.e1-5. PubMed ID: 16569546
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies.
    Gordeuk VR
    Haematologica; 2005 Apr; 90(4):433-4. PubMed ID: 15820926
    [No Abstract]   [Full Text] [Related]  

  • 63. Sildenafil for pulmonary hypertension in ARDS: a new pleasant effect?
    Blanch L; Albaiceta GM
    Intensive Care Med; 2010 May; 36(5):729-31. PubMed ID: 20130829
    [No Abstract]   [Full Text] [Related]  

  • 64. Revatio (sildenafil citrate) for the treatment of pulmonary arterial hypertension.
    Sahni J
    Conn Med; 2006; 70(6):381-3. PubMed ID: 16869470
    [No Abstract]   [Full Text] [Related]  

  • 65. Successful treatment of severe portopulmonary hypertension in a patient with Child C cirrhosis by sildenafil.
    Callejas Rubio JL; Salmerón Escobar J; González-Calvín J; Ortego Centeno N
    Liver Transpl; 2006 Apr; 12(4):690-1. PubMed ID: 16555327
    [No Abstract]   [Full Text] [Related]  

  • 66. Not just for men.
    Prat NM; Sánchez-Dalmau BF; Foroozan R
    Surv Ophthalmol; 2011; 56(2):173-7. PubMed ID: 21035828
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension.
    Barst RJ; Ivy DD; Gaitan G; Szatmari A; Rudzinski A; Garcia AE; Sastry BK; Pulido T; Layton GR; Serdarevic-Pehar M; Wessel DL
    Circulation; 2012 Jan; 125(2):324-34. PubMed ID: 22128226
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sildenafil improves six-minute walk distance in chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial.
    Rao RS; Singh S; Sharma BB; Agarwal VV; Singh V
    Indian J Chest Dis Allied Sci; 2011; 53(2):81-5. PubMed ID: 21545068
    [TBL] [Abstract][Full Text] [Related]  

  • 69. No evidence for severe retinopathy of prematurity following sildenafil.
    Pierce CM; Petros AJ; Fielder AR
    Br J Ophthalmol; 2005 Feb; 89(2):250. PubMed ID: 15665374
    [No Abstract]   [Full Text] [Related]  

  • 70. Priapism in an infant with sickle cell trait after cardiac transplant.
    Bacsu CD; Metcalfe PD
    Urology; 2012 Oct; 80(4):928-30. PubMed ID: 22901818
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sildenafil in pulmonary arterial hypertension.
    Confalonieri M; Antonaglia V; Lucangelo U; Gullo A
    Am J Respir Crit Care Med; 2004 Jun; 169(11):1256; author reply 1256-7. PubMed ID: 15161616
    [No Abstract]   [Full Text] [Related]  

  • 72. A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis.
    ; Zisman DA; Schwarz M; Anstrom KJ; Collard HR; Flaherty KR; Hunninghake GW
    N Engl J Med; 2010 Aug; 363(7):620-8. PubMed ID: 20484178
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pulmonary arterial hypertension occurrence after liver transplant in systemic sclerosis: a report of 2 cases sustainably treated by sildenafil.
    Koumakis E; Wipff J; Kahan A; Allanore Y
    Clin Exp Rheumatol; 2010; 28(2 Suppl 58):S53-4. PubMed ID: 20576215
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Sildenafil is well tolerated by erectile dysfunction patients taking antihypertensive medications, including those on multidrug regimens.
    Böhm M; Burkart M; Baumann G
    Curr Drug Saf; 2007 Jan; 2(1):5-8. PubMed ID: 18690944
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Food and Drug Administration (FDA) postmarket reported side effects and adverse events associated with pulmonary hypertension therapy in pediatric patients.
    Maxey DM; Ivy DD; Ogawa MT; Feinstein JA
    Pediatr Cardiol; 2013 Oct; 34(7):1628-36. PubMed ID: 23532466
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sildenafil decreased pulmonary arterial pressure but may have exacerbated portal hypertension in a patient with cirrhosis and portopulmonary hypertension.
    Wang YW; Lin HC; Yang YY; Hou MC; Lee SD
    J Gastroenterol; 2006 Jun; 41(6):593-7. PubMed ID: 16868809
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sildenafil therapy and exercise tolerance in idiopathic pulmonary fibrosis.
    Jackson RM; Glassberg MK; Ramos CF; Bejarano PA; Butrous G; Gómez-Marín O
    Lung; 2010 Apr; 188(2):115-23. PubMed ID: 20012639
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sildenafil for lung fibrosis and pulmonary hypertension.
    Kleinsasser A; Loeckinger A
    Lancet; 2003 Jan; 361(9353):262-3; author reply 263. PubMed ID: 12547578
    [No Abstract]   [Full Text] [Related]  

  • 79. Sildenafil for pulmonary arterial hypertension: when blue turns into white.
    Antoniu SA
    Expert Opin Pharmacother; 2006 Sep; 7(13):1801-10. PubMed ID: 16925506
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Guidelines for the diagnosis and treatment of pulmonary hypertension].
    Sanchez O; Humbert M; Sitbon O; Jais X; Simonneau G
    Rev Mal Respir; 2010 Feb; 27(2):141-50. PubMed ID: 20206062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.